Do innate-like B cell responses contribute to neonatal immunity?

点击翻译按钮获取中文摘要

The body protects itself from infection via its immune system. We do not completely understand how the immune system works in newborns (either those born at term or prematurely) but we do know that infections are common in this vulnerable patient group and that they can often result in severe illness and death. A better understanding of how this system functions from birth may inform future clinical practice by developing methods to boost the immune response and thereby protect babies. We have already established that T cells, one type of white blood cell that helps protect the body from infection, behave very differently in neonates. We have now identified that a second type of white blood cell, the B cell, that helps protect the body by making antibodies, also exist in different forms in human infants.In this proposal, we want to scrutinise the biology of this B cell population that is enhanced in neonates and determine its role in protecting babies from infection. We have already collected blood from preterm babies (with their parent's permission and at a time when blood was being taken for routine care) and have samples from babies who were well and from babies during periods of infection. This unique resource will allow us to study the peripheral immune system in neonatal health and disease and look at how these B cells respond in preterm infants. We can compare this to babies born at term by looking in cord blood samples. We will also investigate what these B cells develop into, what type of antibodies they make, and when their predominance starts to decline. We will do this by looking in blood samples taken from babies at 1 and 3 months of age. This may potentially provide a therapeutic target to enhance the neonatal immune system and ultimately reduce morbidity and mortality from infection.